Introduction
============

Weight loss response in clinical obesity treatment programs is highly variable^[@bib1],\ [@bib2]^ and there is growing evidence of important biological factors that contribute to inherent differences in oxidative metabolism, and/or adaptation to energy restriction.^[@bib3],\ [@bib4],\ [@bib5],\ [@bib6],\ [@bib7]^ In previous analyses of over 3400 patient records in the Ottawa Hospital Weight Management Program (OHWMP), we documented a two to threefold difference in weight loss response in diet compliant individuals.^[@bib1],\ [@bib2],\ [@bib7],\ [@bib8]^

Here, age-, sex- and initial body weight-matched adherent patients in the upper versus lower quintiles for weight loss in the first 6 weeks of meal-replacement are defined as obese diet-sensitive (ODS) and obese diet-resistant (ODR), respectively.

Using these criteria, ODS patients were found to have a higher proportion of type I muscle fibers; muscle fiber hypertrophy; increased expression of genes involved in oxidative metabolism; higher proton leak in isolated mitochondria and primary myotubes^[@bib2],\ [@bib8],\ [@bib9]^ and greater expression of OXPHOS genes in whole blood prior to diet intervention.^[@bib10]^ Moreover, patients defined as ODR in the meal-replacement program demonstrate impaired weight loss in response to bariatric surgery.^[@bib11]^ These findings are consistent with the hypothesis that capacity for weight loss has an important biological basis.

With the goal of elucidating possible mechanisms, we have interrogated metabolic responses in a newly recruited group of closely matched ODS and ODR individuals under resting fasting conditions and in response to a defined high fat meal (HFM). We report distinct differences in muscle fiber fatty acid-supported respiration, maximal oxidative phosphorylation and circulating protein biomarkers.

Materials/subjects and methods
==============================

Participants
------------

This study was approved by the Ottawa Health Science Network Research Ethics Board and participants provided informed written consent. These included weight stable, sedentary, non-smoking, non-diabetic females, with BMI \>30 kg m^−2^. During the first 12 weeks of the 26 week program, participants consume 900 kcal day^−1^ of Optifast liquid meals (Nestlé Health Sciences). Rate of weight loss, corrected for age, initial body mass and BMI is calculated on the basis of serial measures in the first 6 weeks.^[@bib2],\ [@bib12]^ On the basis of comprehensive compliance measures as described previously^[@bib2],\ [@bib8]^ only diet-adherent women who had previously completed the OHWMP and were strictly identified as ODS or ODR.

Patients in the OHWMP were excluded from data analysis and further metabolic studies if: they did not meet the adherence criteria; they were absent for more than two visits during the initial 6 weeks on meal-replacement; physician notes expressing reservations about self-reported compliance; and/or there was inadequate completion of the laboratory testing protocol. Patients were also excluded from metabolic and clinical research if they had any medical conditions or were taking any medications that may affect rate of weight loss including prior bariatric surgery, use of any medication known to affect rate of weight loss or glucose homeostasis, abnormal thyroid indices, congestive heart failure, malignancy or obstructive sleep apnea (during the program or at the time of biopsy). Ten pairs of ODS and ODR subjects not previously studied were matched for age (±10 years), body mass (±10 kg) and BMI (±2 kg m^−2^) at program enrollment and at the time of study (±10 years).

Study design
------------

### Meeting 1

Participants maintained normal daily activities and physical activity during waking hours for the preceding 7 days was determined using Actical accelerometers (Bend, OR, USA) and written records. After an overnight fast, anthropometric measures including DEXA scan were obtained.

### Meeting 2: Trial day

Participants consumed a standardized meal and arrived by taxi at 0700 hours after a 12 h fast and were met with a wheelchair, to minimize exertion.

### Indirect calorimetry

Participants rested supine in the dark for 20 min. Expired gases were collected for 30 min using a hood (Vmax Encore 29N, SensorMedics, Yorba Linda, CA, USA). Following the HFM, gases were collected for 30 min at 1, 2, 3, 4 and 5 h. Fuel utilization was determined.^[@bib13]^ Throughout the remainder of the day, when participants were not undergoing expired gas collection, they remained in a resting seated or reclined position. Urine was quantitatively collected for urea determination to assess protein oxidation.

### Blood sampling

Samples were at 30 min intervals from 0 h (baseline) to 6 h via a forearm catheter.

### Muscle biopsies

Pre and 6 h post-HFM, *vastus lateralis* biopsies were obtained using a Bergstrom needle in alternate legs. Muscle was placed immediately in ice-cold saline: 20--30 mg was transferred to ice-cold BIOPS^[@bib14]^ for respiration and reactive oxygen species (ROS) measurements; the remaining tissue was flash frozen.

### High fat meal

Following baseline sampling, participants consumed within 5 min a liquid HFM, modified from^[@bib15]^ equivalent to 35% of total daily energy requirements (TDE). TDE was determined from the sum of resting metabolic rate (RMR; determined from indirect calorimetry), average daily energy expended from physical activity and the thermic effect of food (assumed 10% TDE).

Analyses of tissues, plasma and primary cells
---------------------------------------------

### High resolution respirometry

Permeabilized muscle fibers (1--4 mg) were prepared and analyzed in duplicate, at 37 °C, with 200--400 nmol O~2~/l^[@bib14]^ in an Oxygraph O2K (Oroboros, Innsbruck, Austria).

### Protocol 1

Routine leak in the absence of adenylates was measured in the presence of 1.5 m[m]{.smallcaps} malate (M) and 200 μ[m]{.smallcaps} octanoylcarnitine (OC), followed by 5 m[m]{.smallcaps} ADP to assess state 3 FA-supported respiration. Maximal OXPHOS was measured with complex I substrates (5 m[m]{.smallcaps} pyruvate (P) and 10 m[m]{.smallcaps} glutamate (G)) followed by succinate (10 m[m]{.smallcaps}; (S)), and additional ADP. State 4 was assessed with oligomycin (Oligo; 2.5 μ[m]{.smallcaps}). Non-mitochondrial respiration was assessed with antimycin A (AA; 2.5 μ[m]{.smallcaps}). Cytochrome *c* oxidase (COX) activity was measured with tetramethylphosphodinitrate (TMPD; 5 m[m]{.smallcaps}), and ascorbate (5 m[m]{.smallcaps}). Autoxidation of TMPD was inhibited with sodium azide (100 m[m]{.smallcaps}).

### Protocol 2

Complex I and downstream complexes were assessed with M and P, followed by ADP and G. Maximal OXPHOS was measured with S and ADP reinjections. Cytochrome C (Cyt C; 10 μ[m]{.smallcaps}) was injected to confirm integrity of the mitochondria; respiration rates did not increase \>5% of OXPHOS. Maximal uncoupled respiration was measured with FCCP (0.25--1 μ[m]{.smallcaps}). Non-mitochondrial respiration was that remaining in the presence of AA. Maximal capacity of COX was measured with TMPD, as above.

### H~2~O~2~ emission

H~2~O~2~ emission was measured in \~10 mg of permeabilized muscle prepared using the Oxygraph O2K fluorimeter, as described.^[@bib16]^

### Western blots

Proteins were blotted for: total OXPHOS (1:1000, ab-22604, Abcam, Cambridge, UK), and HSP72 (1:5000; C92F3A-S, Enzo Life Sciences, Farmingdale, NY, USA) and analyzed using enhanced chemiluminescence, and Image J software with vinculin (1:1000, ab129002, Abcam) or Ponceau as loading controls.

### Enzyme activities

Citrate synthase and β-HAD activities were determined as described.^[@bib17],\ [@bib18]^

### Plasma analytes

Standard kits were used: glucose (Sigma Aldrich, St Louis, MO, USA); free fatty acids and triglycerides (WAKO Diagnostics, Richmond, VA, USA); insulin (Sigma Aldrich).

### Primary myotubes

Muscle satellite cells were isolated from *vastus lateralis* of ODR (42±5 year; 96.7±4.8 kg; BMI: 34.0±1.5 kg m^−2^, *n*=5) and ODS (42±3 year; 97.7±4.8 kg; BMI: 35.8±0.5 kg m^−2^, *n*=5).^[@bib9],\ [@bib19]^ On day 6, cells were treated with differentiation media containing 2% BSA and 1 m[m]{.smallcaps} carnitine with or without 500 μ[m]{.smallcaps} palmitate for 24 h.

### Reactive oxygen species

Cellular ROS emission was measured in a 96-well plate using 2′,7′--dichlorofluorescin diacetate.^[@bib9]^

### Fatty acid oxidation

Myotubes were grown to confluence in a 12-well plate and induced to differentiate for 7 days. FA oxidation was measured as described.^[@bib20]^

### Plasma acylcarnitine levels

Methods were as previously described^[@bib21]^ with minor modifications,^[@bib16]^ using baseline, 0.25, 0.5, and 1- 6 hourly samples.

### Plasma proteomics

Analyses were performed on plasma collected at baseline and at 1, 2, 5, 6 h following the HFM using SOMAscan technology (Somalogics, Boulder, CO, USA). Each of the 1130 plasma proteins in the SOMAscan assay has a targeted SOMAmer ([S]{.ul}low [O]{.ul}ff-rate [M]{.ul}odified [A]{.ul}ptamer) reagent, which is used as an affinity-binding reagent and quantified on a custom Agilent hybridization chip. ODS and ODR samples were randomly assigned to plates within each assay and run along with a set of calibration and normalization samples. Intra-run normalization and inter-run calibration were performed according to SOMAscan v3 quality-control procedures.^[@bib22]^

### Isolation and analysis of plasma exosomes, and effects on muscle cells

Exosomes were isolated from 1.0 ml of plasma using differential ultracentrifugation and analyzed to confirm quality and quantity using Zetaview, as previously described.^[@bib23]^ C2C12 myoblasts were seeded at 10 000 cells per well in 96-well Seahorse cell culture plates and differentiated 7 days. Myotubes were treated in pentuplicate with isolated exosomes in a substrate-limited media (DMEM with 0.5 m[m]{.smallcaps} glucose, 1 m[m]{.smallcaps} glutamine, 0.5 m[m]{.smallcaps} carnitine, 1% FBS) for 24 h. There was no significant difference in the absolute concentration of exosomes across patient groups, and the exosome final concentrations in the medium approximated that in plasma *in vivo*. A standard FA oxidation assay (Seahorse XFe96, Santa Clara, CA, USA) was performed in the presence of palmitate-conjugated BSA or a BSA control. Data were normalized to protein concentration.

Statistical analysis
--------------------

Two-way ANOVA with Bonferroni *post hoc* analyses were used to assess meal and group effects. One-way ANOVA was used to assess differences in body mass, BMI and age. For plasma proteomics, repeated measures ANOVA was used for group effects, time effects and group × time effects. Biomarkers remaining significant after correction for multiple testing (*n*=1130) including Bonferroni-corrected *P*\<0.05, Benjamini--Hochberg FDR *q*\<0.05 and local false discovery rates (LFDR) \<0.05 were selected as significant hits. All statistical analyses were conducted in R (version 3.0.1, Vienna, Austria) and Prism (Version 7.0; GraphPad; La Jolla, CA, USA).

Results
=======

Anthropometry and weight loss characteristics
---------------------------------------------

Prior to enrollment in the weight loss program, there were no differences in age, body mass or BMI. Following 6 week of dietary restriction, ODS women lost 44% more weight compared to ODR (ODR vs ODS; 6.9±0.5 kg, vs 11.5±0.6 kg, *P*\<0.001; [Table 1](#tbl1){ref-type="table"}). At the time of the HFM challenge, age, body mass, BMI, waist circumference, body fat mass and lean mass were similar between ODS and ODR ([Table 1](#tbl1){ref-type="table"}). As in a previous study,^[@bib8]^ there were no differences between groups in daily physical activity ([Table 1](#tbl1){ref-type="table"}).

Following the HFM, whole-body O~2~ consumption, CO~2~ production and TEE increased over time to a similar extent in the two groups ([Figures 1a, b and e](#fig1){ref-type="fig"}; *P*\<0.0001, effect of time, *e*; effect of time vs time 0). As expected, lipid utilization increased over time, whereas reliance on carbohydrate decreased ([Figures 1c and d](#fig1){ref-type="fig"}; *P*\<0.01).

Plasma FA, TAG, glucose and insulin all increased over time, but were not different between groups. Plasma FA initially dropped (0--2 h) after the HFM then levelled-off, and began to increase at 4 h ([Figure 1f](#fig1){ref-type="fig"}; *P*\<0.0001), whereas TG, glucose and insulin increased in both groups and began to decline at \~4 h, coinciding with the rise in FA ([Figures 1g, i and d](#fig1){ref-type="fig"}; *P*\<0.0001).

Metabolic characteristics of skeletal muscle fibers
---------------------------------------------------

For the first time, we have investigated oxidative processes in isolated muscle fibers of ODS and ODR patients, and compared group responses to a HFM. Following the HFM, FA-supported respiration was significantly increased in both groups ([Figure 2a](#fig2){ref-type="fig"}; *P*\<0.001) and tended to be higher in ODS vs ODR fibers (*P*=0.09). We also probed for differences in activity of the electron transport complexes and observed a post-meal increase in complex I (*P*~MPG~), that occurred in both groups ([Figure 2b](#fig2){ref-type="fig"}; *P*\<0.01). Importantly, the maximal oxidative phosphorylation rate through complex I, II and ETF (P~MOPGS~) was greater in ODS vs ODR ([Figure 2c](#fig2){ref-type="fig"}; *P*\<0.05) with a group difference following the meal. When we used traditional OXPHOS substrates, we also found higher respiration in ODS ([Figure 2d](#fig2){ref-type="fig"}; *P*=0.06). Moreover, maximal OXPHOS capacity was greater in ODS vs ODR fibers ([Figure 2e](#fig2){ref-type="fig"}; *P*\<0.05). Non-phosphorylating respiration measured in the presence of malate and pyruvate, and in the presence of oligomycin did not differ between groups.

We then sought to determine if differences in fiber energetics were related to mitochondrial content. However there was no difference in OXPHOS protein levels ([Figure 2f](#fig2){ref-type="fig"}), citrate synthase activity ([Figure 2g](#fig2){ref-type="fig"}) or muscle fiber COX activity ([Figure 2i](#fig2){ref-type="fig"}) between ODS and ODR. We also measured β-HAD activity, as a marker of FA oxidative capacity, and there were no difference between groups ([Figure 2h](#fig2){ref-type="fig"}). Moreover, when we normalized FA-supported maximal OXPHOS and uncoupled respiration to COX activity, rates remained higher in ODS vs ODR ([Figures 2j--l](#fig2){ref-type="fig"}, *P*\<0.05). Altogether, these findings demonstrate greater FA-driven respiration and OXPHOS system activity in fibers of ODS vs ODR that are not due to differences in mitochondrial content.

As the formation of mitochondrial supercomplexes promotes electron flow through the ETS,^[@bib24]^ we measured supercomplexes in skeletal muscle. There were no differences between groups or in response to the HFM ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}). Thus, differences in muscle energetics between groups and following the HFM are not due to changes in ETS supercomplexes.

FA oxidation
------------

As circulating acylcarnitines can be indicative of disordered FA oxidation,^[@bib25]^ we measured plasma acylcarnitines at baseline and after the HFM. Short (C2--C4), medium (C6--C10) and long chain (C12-C18) acylcarnitines changed over time ([Figures 3a--c](#fig3){ref-type="fig"}; *P*\<0.01, effect of time), with an initial increase at 15 min. Medium chain acylcarnitines were significantly affected by the HFM ([Figure 3b](#fig3){ref-type="fig"}; ODR 15 min vs 2, 3, 4, 5 h, *P*\<0.05; ODS 15 min vs 3 h, 5 h, *P*\<0.05) and peaked again at 6 h in ODR (6 h vs 3 h, *P*\<0.05) but not in ODS. The AUC for long chain acylcarnitines was lower in ODS (*P*=0.06) suggesting that FA oxidation is more complete in ODS.

We then assessed FA oxidation in cultured primary myotubes from ODS and ODR individuals with or without glucose pre-treatment ([Figures 3d--h](#fig3){ref-type="fig"}). As expected, glucose pre-incubation decreased FA oxidation ([Figures 3d--h](#fig3){ref-type="fig"}). Complete, incomplete (acid soluble product (ASP) in the media+ASP in the cells) and total FA oxidation were similar between groups. Interestingly, in ODR cellular ASP and incomplete FA oxidation did not differ in the presence of glucose ([Figures 3e and f](#fig3){ref-type="fig"}) indicative of reduced metabolic flexibility.

Oxidative stress
----------------

A similar HFM was reported to increase muscle ROS.^[@bib15]^ Interestingly, we found that ROS emissions were higher in ODS vs ODR, with no HFM effect ([Figure 3i](#fig3){ref-type="fig"}). We also assessed ROS in primary myotubes following 24 h of 500 μ[m]{.smallcaps} palmitate exposure. Palmitate increased ROS (overall effect), and in ODS specifically ([Figure 3j](#fig3){ref-type="fig"}), consistent with observed increases in ROS in ODS *ex vivo* muscle (above).

As a measure of oxidative damage, protein carbonyls did not differ in muscle (group or HFM effects), but the HFM increased carbonylation in adipose in both groups ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}; *P*\<0.05).

Plasma proteomic biomarkers
---------------------------

To potentially identify biomarkers of diet responsiveness, we conducted proteomic analyses of 1130 proteins in plasma collected at baseline, 1, 2, 5 and 6 h after the HFM. QQ plots of *P*-values for the group effects, and group-time interaction effects are shown in [Figures 4a and e](#fig4){ref-type="fig"}, respectively. Local false discovery rate and *Q*-values are available in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. After correction for multiple testing, proteins differing between groups (regardless of the fasted or fed states) included S-formyl glutathione hydratase (esterase D), heat shock 70 kDA protein 1 A/B (heat shock protein 72; HSP72), and eukaryotic translation initiation factor 5 (group effect, [Figures 4b--d](#fig4){ref-type="fig"}). Moreover, plasma aryl hydrocarbon receptor-interacting protein (AIP; also known as ARA9, part of the acryl hydrocarbon receptor protein complex), peptidylprolyl isomerase D (PPID; also known as cyclophilin D) and tyrosine protein-kinase Fgr (FGR) increased in ODR following the HFM (group × time effect, [Figures 4f--h](#fig4){ref-type="fig"}). Additional proteins of interest that were nominally significant include glutathione-S transferase P ([Figure 4i](#fig4){ref-type="fig"} group effect; *P*\<0.01), tyrosine protein phosphatase non-receptor 11 (SHP2, [Figure 4j](#fig4){ref-type="fig"}, group effect; *P*\<0.01) higher in ODS and brain derived neurotrophic factor (BDNF; [Figure 4k](#fig4){ref-type="fig"} group × time effect, *P*\<0.05) and Peptide YY (PYY [Figure 4l](#fig4){ref-type="fig"}, group × time, *P*\<0.01).

Plasma HSP72 levels were higher in ODS versus ODR in both fasted and fed states (group effect, Bonferroni-corrected, *P*\<0.05; [Figure 4c](#fig4){ref-type="fig"}). HSP72 has a role in reducing inflammation and insulin resistance in obesity and high fat feeding,^[@bib26]^ and as we hypothesized, baseline HSP72 was positively correlated with FA-supported respiration (P~MO3~, *P*\<0.05 [Figure 4m](#fig4){ref-type="fig"}), OXPHOS (P~MOPGS3~, *P*\<0.05, [Figure 4n](#fig4){ref-type="fig"}), complex I respiration (P~MP3~, *P*=0.05, [Figure 4o](#fig4){ref-type="fig"}) and citrate synthase activity (*P*=0.05, [Figure 4p](#fig4){ref-type="fig"}). Muscle HSP72 protein expression was not different between ODS and ODR ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}).

Effects of plasma exosomes on muscle cell energetics
----------------------------------------------------

As HSP72 and the other identified proteins circulate in exosomes, which are biologically potent,^[@bib27],\ [@bib28],\ [@bib29],\ [@bib30]^ and our results demonstrated a FA oxidation defect in ODR vs ODS muscle ([Figures 2a](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), we investigated the ability of plasma exosomes from ODS and ODR to elicit effects on FA metabolism in a well characterized muscle cell line.

Exosome size distribution and the median size analyses demonstrated successful isolation of exosomes^[@bib31],\ [@bib32],\ [@bib33]^ and no differences in size or plasma concentration between groups ([Figures 5a and b](#fig5){ref-type="fig"}; [Supplementary Figure 4](#sup1){ref-type="supplementary-material"}). Differentiated C2C12 myotubes were treated with exosomes from 1.0 ml of fasting (0 h) or fed (5 h post-HFM) plasma. Exosomes from ODS fasting plasma elicited resting, leak, and maximal oxygen consumption rates (OCRs) that were 58%, 21%, and 51% higher, respectively, as compared to exosomes from fasting ODR plasma ([Figure 5c](#fig5){ref-type="fig"}). In contrast, resting glycolysis rates were higher in ODR than ODS by 67% ([Figure 5d](#fig5){ref-type="fig"}). When OCRs were plotted against extracellular acidification rates (ECARs) to delineate the metabolic poise of cells, myotubes treated with fasting ODS exosomes are clearly less glycolytic and have a greater oxidative flexibility than the cells treated with the fasting ODR exosomes ([Figure 5e](#fig5){ref-type="fig"}). Interestingly, although exosomes isolated from the plasma taken 5 h after the HFM caused some stimulation of oxidative and glycolytic activities in the C2C12 cells, there were no differences between ODS and ODR groups ([Figures 5f--h](#fig5){ref-type="fig"}).

Discussion
==========

Here we have further interrogated the complex biology underlying weight loss variability in obesity. We focused on mechanisms in plasma and skeletal muscle related to fuel oxidation and metabolic flexibility *in vivo* and *in vitro*. We demonstrate that both FA-supported muscle respiration and maximal oxidative phosphorylation are greater in ODS vs ODR individuals under fasting, resting conditions, and following a high fat meal. These differences are independent of muscle mitochondrial content and oxidative phosphorylation supercomplex assembly. Seeking possible plasma markers of diet sensitivity vs resistance we surveyed 1130 circulating proteins before and at several time points after the HFM and identified several proteins that were either different between groups or exhibited different post-meal trajectories. HSP72 was positively correlated with muscle fiber respiration and citrate synthase activity. Given that all of the identified proteins circulate in exosomes, another key finding is that plasma exosomes from ODS stimulate oxidative metabolism in muscle cells to a greater extent than those from ODR.

In permeabilized muscle fibers in which mitochondrial structures remain intact and highly functional, we demonstrate that FA-supported respiration, oxidative phosphorylation with NADH- and FADH~2~-mediated electron supply through complexes I and II and the maximal capacity of the ETS were higher in ODS muscle. In addition, NADH-driven respiration through complex I is acutely increased following a HFM, consistent with the control of mitochondrial oxidative capacity through acute processes, such as post-translational modifications. Differences in mitochondrial respiration are often ascribed to differences in mitochondrial content.^[@bib14],\ [@bib34],\ [@bib35],\ [@bib36]^ Despite the use of various well recognized techniques, we observed no difference in mitochondrial content.

Mitochondrial ETS proteins interact to form supercomplexes, and dysfunctional supercomplexes are associated with aging,^[@bib37]^ cardiovascular disease^[@bib38]^ and type 2 diabetes,^[@bib39]^ which may be related to oxidative stress.^[@bib40]^ In the current study, muscle mitochondrial supercomplex were not different between ODS and ODR. Thus the observed differences in mitochondrial respiration (group and meal effects) may be a result of post-translational modification of ETS proteins, which will require further study.

Consistent with a lower capacity for FA oxidation in ODR muscle, plasma long chain acylcarnitines and peak medium chain acylcarnitines (15 min, 6 h) were higher in ODR than ODS. Acylcarnitines are intermediary metabolites of FA oxidation. Circulating acylcarnitines can be indicative of FA oxidation dysfunction,^[@bib25],\ [@bib41],\ [@bib42]^ and plasma and skeletal muscle acylcarnitine profiles can be abnormal in obesity.^[@bib41],\ [@bib43],\ [@bib44]^ Owing to the tissue constraints, we were unable to measure muscle acylcarnitines. We did however observe metabolic inflexibility in primary myotubes of ODR individuals. Indeed, FA-supported respiration in permeabilized muscle fibers was also lower in ODR. Taken together, findings indicate that FA metabolism is impaired in skeletal muscle of ODR individuals.

Plasma proteomics revealed that FGR, PPID and AIP increased in ODR following the HFM. FGR, a Src kinase, interacts with succinate dehydrogenase and aconitase.^[@bib45]^ Redox sensitive Src kinases and tyrosine kinases have been found in mitochondria and can be activated by H~2~O~2~ or oxidative stress.^[@bib46],\ [@bib47]^ Src kinase is decreased in cardiac tissue in sepsis and associated with decreased tyrosine phosphorylation and activity of OXPHOS proteins.^[@bib48]^ PPID (cyclophilin D) is an important regulator of mitochondrial physiology and interacts with proteins including glycogen synthase kinase 3, adenine nucleotide translocator, F~1~F~O~ ATP synthase and the mitochondrial permeability transition pore (MPTP).^[@bib49]^ MPTP has a key role in apoptosis as well as calcium handling and metabolism^[@bib50]^ and the *PPID* locus is linked to serum metabolite levels.^[@bib51]^ Finally, AIP (ARA9) is part of the aryl hydrocarbon receptor protein complex (AHR), which influences cell cycle, death, xenobiotic metabolism, and mitochondrial function, potentially through its interaction with ATP5α1. The unique increases in the levels of these circulating proteins in ODS, and the absence of responses in ODR may contribute at least in part to the observed differences in muscle mitochondrial metabolism following the HFM.

Proteomics also revealed that levels of esterase D, eIF5 and HSP72 are higher in ODS vs ODR. Esterase D is also referred to as S-formyl glutathione hydrolase, and is thought to hydrolyze a formyl group from S-formyl glutathione yielding glutathione.^[@bib52]^ This may be relevant given that glutathione is the most important non-protein antioxidant in cells and also has a role in controlling mitochondrial protein activity through glutathionylation.^[@bib53],\ [@bib54]^ Glutathione redox is impaired in aging and many metabolic disorders^[@bib55]^ and we previously reported that glutathione redox (GSH:GSSG) is impaired in primary myotubes of ODR compared to ODS.^[@bib9]^ Further research is required to elucidate how glutathione metabolism becomes disordered in muscle of diet-resistant individuals. eIF5 is a protein translation initiation factor and catalyzes GTP hydrolysis from the 40S ribosomal initiation complex. It is possible that there are differences in protein translation in diet-resistant individuals, and this would require additional study.

Of particular interest, we found that plasma HSP72 was higher in ODS, and positively correlated with muscle FA-supported respiration, OXPHOS activity, citrate synthase activity and complex I respiration. HSPs mitigate oxidative stress and inflammation by acting as chaperones for naïve, aberrantly folded or mutated proteins.^[@bib56]^ Muscle HSP72 expression is decreased in obesity^[@bib26]^ and type 2 diabetes^[@bib57]^ and correlates with muscle oxidative capacity in humans.^[@bib57]^ HSP72 overexpression in muscle reduces high fat diet-induced inflammation, weight gain, and increases whole-body energy metabolism and mitochondrial content.^[@bib26],\ [@bib58]^ Interestingly, we did not find any difference in skeletal muscle HSP72 expression between ODS and ODR, despite the profound difference observed in plasma and its correlation with skeletal muscle oxidative capacity. Previous studies have found skeletal muscle HSP72 levels to be low in physiological states characterized by mitochondrial dysfunction (that is, type 2 diabetes). Some studies that have shown skeletal muscle HSP72 to be low in physiological states characterized by mitochondrial dysfunction, measured mRNA but not protein levels. As HSP72 is a stress-induced protein that controls protein turnover and chaperones proteins within cells and out of cells, HSP72 turnover is high, and this is controlled through HSP72 ubiquitination.^[@bib59]^ Thus differences may be more apparent at the mRNA level, than the protein level. It has also been proposed that HSP72 may act as a myokine, thereby supporting the possibility of its active excretion from muscle.^[@bib60]^ Unfortunately, due to tissue constraints we were unable to measure HSP72 mRNA expression. On the basis of the high proportion of total body mass that is skeletal muscle (\~40%), and on prior research that links oxidative metabolism and skeletal muscle HSP72 levels,^[@bib26],\ [@bib57],\ [@bib58]^ we feel that skeletal muscle is a likely source of plasma HSP72 in the current study. Further studies will need to be conducted to decipher the main source of plasma HSP72.

As proof-of-concept we then explored how these proteins (which circulate in exosomes) might affect muscle metabolism, and found that exosomes from ODS vs ODR groups differentially altered myotube FA metabolism. Fasting plasma exosomes from ODS enhanced FA oxidation, whereas ODR exosomes enhanced glycolysis, despite excess palmitate in the medium. ODS exosomes stimulated proton leak uncoupling; proton leak was previously found to be higher in isolated muscle mitochondria and in primary myotubes of ODS vs ODR.^[@bib2],\ [@bib9]^ However, we did not detect increased leak on ODS vs ODR permeabilized myofibers herein, an observation possibly due to differences in tissue preparation and incubation conditions.

Treatment of C2C12 cells with exosomes from the 5 h post-HFM time point resulted in a similar metabolic phenotype between groups; the effect of the group seems to be overpowered by the effect of the meal. Given the distinct differences in the circulating proteome following the meal, it is quite likely that different mechanisms are involved. Future studies should focus on the proteome, microRNA and mRNA content of the ODS and ODR exosomes, in fasted and fed states.

Skeletal muscle accounts for about 20% of total resting energy expenditure,^[@bib61]^ which may explain in part why no measurable difference was observed in resting and postprandial whole-body energetics between ODR and ODS individuals despite marked differences in skeletal muscle metabolism observed.^[@bib2],\ [@bib9],\ [@bib12]^ Undoubtedly, detection of differences in whole-body energy expenditure between ODS and ODR require longer time frames than the 30 min used here. It may be that differences in whole-body energy metabolism could be detected during exercise; this will be pursued in an upcoming study.

We also sought to investigate ROS and oxidative stress and observed higher ROS emission and glutathione-S transferase in ODS and increased ROS emission response to palmitate in primary myotubes from ODS, suggesting that ODS may have a greater capacity to respond to ROS compared to ODR. Contrary to Anderson *et al.*^[@bib15]^ who found increased ROS emission 4 h following a HFM, we did not find increased oxidative stress following the HFM in either group. However, at 6 h we may have missed the maximal effect of the HFM; indeed, plasma TG and insulin began to decline at 4 h.

In summary, we provide novel insights into the biology underlying weight loss resistance, including lower muscle fiber oxidative characteristics independent of mitochondrial content or supercomplex assembly and metabolic inflexibility (cellular FA oxidation, plasma acylcarnitines). Multiple differences in the plasma proteome provide exciting clues relevant to diet resistance, and provide potentially useful biomarkers to predict weight loss success. In particular, greater HSP72 correlated with muscle respiration. Finally, the differential effects of plasma exosomes from ODS vs ODR on muscle cell metabolism are consistent with the possibility that factors circulating in exosomes could contribute to weight loss variability and lead to novel therapeutic approaches.
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![Whole-body response to the high fat meal in ODS and ODR individuals. Whole-body VO~2~ (**a**), VCO~2~ (**b**), carbohydrate utilization (**c**), lipid utilization (**d**) and total energy expenditure (**e**) at baseline and in response to the HFM. Plasma fatty acids (**f**), triglyceride (TG; (**g**, **h**) glucose and (**i**) insulin at baseline (0 min) and following a high fat meal in ODR and ODS individuals. Two-way ANOVA, significant effect of time, **f**--**i**: *P*\<0.0001; **a**--**d**: *P*\<0.01. (**e**) Total energy expenditure, Significant effect of time *P*\<0.05, *post hoc* significantly different from baseline within group. Data are mean±s.e.m., *n*=9--10.](ijo2017286f1){#fig1}

![Skeletal muscle mitochondrial respiration but not content is increased in ODS compared to ODR prior to and in response to the high fat meal. Mitochondrial respiration was measured in permeabilized muscle fibers of ODS and ODR individuals pre and post the high fat meal. (**a**) State 3 fatty acid-supported respiration with 2 m[m]{.smallcaps} malate (M), 200 μ[m]{.smallcaps} octanoylcarnitine and 5 m[m]{.smallcaps} ADP (P~MO3~). Two-way ANOVA, *P*=0.09, effect of group, \**P*\<0.05 significant effect of meal. (**b**) State 3 complex I respiration with electron supply from 2 m[m]{.smallcaps} malate, 5 m[m]{.smallcaps} pyruvate (P), 10 m[m]{.smallcaps} glutamate (**g**) (P~MPG3~). \**P*\<0.05, significant effect of meal. (**c**) Maximal oxidative phosphorylation with electron supply to complex I and II with substrate M, OC, P, G and 10 m[m]{.smallcaps} succinate (S)+ADP (P~MOPGS3~). \**P*\<0.05 two-way ANOVA, significant effect of group, a *post hoc* significantly different between groups. (**d**) Maximal oxidative phosphorylation with electron supply to complex I and II with substrate M, P,G, S (P~MPGS3~), *P*=0.06, two-way ANOVA, effect of group. (**e**) Maximal capacity of the electron transfer system, as measured with the chemical uncoupler FCCP. \**P*\<0.05 significant effect of group. (**f**) Expression of electron transfer system proteins (complex I, II, III, IV, V), (**g**) citrate synthase activity and (**h**) beta HAD activity in skeletal muscle of ODR and ODS at baseline. (**i**) COX activity in permeabilized muscle fibers of ODS and ODR was measured with 5 m[m]{.smallcaps} TMPD maintained in a reduced state by 5 m[m]{.smallcaps} ascorbate and reducing cytochrome C as the substrate. (**j**) FA-supported respiration expressed per COX activity. \*Two-way ANOVA, significant effect of group. \*\**P*\<0.01, significant effect of meal, *post hoc* significantly different post between ODS and ODR. (**k**) Maximal oxidative phosphorylation (P~MOPGS3~) expressed per COX activity. \**P*\<0.05 two-way ANOVA significant effect of group. (**l**) Maximal oxidative phosphorylation (P~MPGS3~) expressed per COX activity. \**P*\<0.05 two-way ANOVA significant effect of group and meal. Data are mean±s.e.m.](ijo2017286f2){#fig2}

![FA metabolism and oxidative stress in ODS and ODR. Plasma (**a**) short, (**b**) medium and (**c**) long chain acylcarnitine content and area under the curve (AUC) in ODS and ODR at baseline and in response to the HFM. Two-way ANOVA, Bonferroni *post hoc*, significant effect of time \*\**P*\<0.01, \*\*\**P*\<0.001. Data are mean±s.e.m. (*n*=9). (**d**--**h**) FA oxidation in myotubes derived from ODR and ODS±glucose pre-treatment to test metabolic flexibility. (*N*=5) Data are mean±s.e.m. Two-way ANOVA, line above graph indicates significant effect of glucose \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. (**d**) ASP in the media, *post hoc* effect of glucose ODR \*\**P*\<0.01, ODS \*\*\**P*\<0.001 (**e**) ASP in the cell, *post hoc* effect of glucose, ODS \**P*\<0.05; (**f**) Incomplete FA oxidation, *post hoc* effect of glucose, ODS *P*\<0.01; (**g**) Complete FA oxidation to CO~2~ production, *post hoc* effect of glucose ODR, \**P*\<0.05, ODS \*\*\**P*\<0.001; and (**h**) total FA oxidation, *post hoc* effect of glucose ODR \**P*\<0.05, ODS \*\**P*\<0.01. (**i**) Oligomycin-induced H~2~O~2~ emission in skeletal muscle of ODS and ODR pre and post-HFM. \**P*\<0.05 Two-way ANOVA, significant effect of group (*N*=7--8). (**j**) ROS emission in myotubes derived from ODS and ODR with and without 24 h 500 μ[m]{.smallcaps} palmitate treatment. Two-way ANOVA \*\**P*\<0.01 significant effect of treatment. A *P*\<0.05 *post hoc* significant difference from control condition within ODS *n*=5.](ijo2017286f3){#fig3}

![Plasma proteins at baseline and in response to a high fat meal in ODR and ODS individuals. (**a**) QQ plot---group analysis, (**b**) Esterase D, (**c**) heat shock protein 70 1 A/1B (HSP72) and (**d**) eukaryotic translation initiation factor 5 (eIF5); significant effect of group. (**e**) QQ plot---group × time analysis (**f**) aryl hydrocarbon interacting protein (AIP), (**g**) PPID and (**h**) tyrosine protein-kinase Fgr (FGR); significant different group × time, two-way repeated measures ANOVA, Bonferroni-corrected *P*-value, *Q*-value and LFDR\<0.05 \*\**P*\<0.01, \**P*\<0.05). (**i--l**) Nominally significant plasma proteins at baseline and in response to the high fat meal. Group effect: (**i**) Glutathione-S transferase and (**j**) tyrosine protein phosphatase non-receptor type 11 (SHP2). Group × time effect: (**k**) brain derived neurotropic factor (BDNF) and (**l**) Protein YY (PYY). Two-way repeated measures ANOVA, \*\**P*\<0.01, \**P*\<0.01. HSP72 is positively correlated to (**m**) FA-supported respiration in muscle fibers (P~MO3~), (**n**) OXPHOS activity in muscle fibers (P~MOPGS3~), (**o**) complex I respiration in muscle fibers (P~MP3~) and (**p**) skeletal muscle citrate synthase activity. Data are mean±s.e.m., *n*=9--10.](ijo2017286f4){#fig4}

![Differential metabolic effects of ODS and ODR plasma-derived exosomes on differentiated myotubes. Cellular respiration and extracellular acidification was measured in 7 day differentiated C2C12 myotubes in response to exosomes isolated from plasma samples pre (ODS *n*=9, ODR *n*=9) and 5 h post (ODS *n*=9, ODR *n*=8) HFM. (**a**) Representative Zetaview analysis of the size distribution of the vesicles. (**b**) Median sizes of the exosomes for ODS and ODR groups. (**c**, **f**) Cellular oxygen consumption rates (OCR) at rest, following oligomycin injection (3 μ[m]{.smallcaps}; proton leak), and FCCP injection (2 μ[m]{.smallcaps}; maximal respiration) with exosomes isolated from fasted (0 h) or post-HFM (5 h) respectively. (**d**, **g**) Extracellular acidification rates (ECAR) at rest, and following oligomycin and FCCP injection (maximal glycolysis) with exosomes isolated from fasted (0 h) or post-HFM (5 h) respectively. (**e**, **h**) Graph illustrating the metabolic flexibility from resting OCR and ECAR (left data points) and following oligomycin and FCCP injection (right data points). Data are mean±s.e.m., *n*=8--9, \**P*\<0.05, \*\**P*\<0.01.](ijo2017286f5){#fig5}

###### Anthropometric characteristics before, 6 weeks following meal-replacement and at the time of biopsy

                                              *ODR*          *ODS*
  ---------------------------------------- ----------- ------------------
  *N*                                          10              10
  *Before meal-replacement*                            
   Age (years)                                44±2            43±2
   Mass (kg)                                104.8±6.9      100.3±3.9
   BMI (kg m^−2^)                           37.7±2.0        37.8±1.1
                                                                
  *Following 6 weeks of 900 kcal diet*                 
   Mass (kg)                                98.0±6.5      88.6±3.4\*\*
   BMI (kg m^−2^)                           35.2±1.5      33.2±1.0\*\*
   % Weight loss                             6.5±0.2    11.7±0.2\*\*\*\*
                                                                
  *At time of biopsy*                                  
   Age (yr)                                   48±2            52±2
   Mass (kg)                                100.9±7.3       93.2±5.9
   BMI (kg m^−2^)                           37.1±2.0        35.6±1.7
   Waist circumference (cm)                 113.9±4.7      112.1±4.2
   Body fat (%)                             49.8±1.8        47.4±1.2
   Fat mass (kg)                            46.7±4.1        42.5±3.1
   Lean mass (kg)                           45.4±2.3        46.9±3.1
   Respiratory quotient                     0.79±0.02      0.80±0.02
   VO~2~ (l min^−1^)                        0.23±0.01      0.23±0.01
   VCO~2~ (l min^−1^)                       0.18±0.01      0.18±0.01
   Resting metabolic rate (kcal day^−1^)     1584±85        1604±86
   Physical activity (kcal)                 1222±216        1121±181
   TDEE (kcal day^−1^)                      3087±213        3004±216
   HOMA-IR                                   9.2±1.9        13.1±2.9

\*\*Two-way ANOVA, significantly different compared to before meal-replacement within group, *P*\<0.01.

\*\*\*\**P*\<0.0001 two-tailed unpaired *t*-test. Body fat distribution, *P*\<0.05, two-tailed unpaired *t*-test.

Data are mean±s.e.m., *n*=10.

[^1]: These authors contributed equally to this work.
